glutathione for als in the Nervous System as a Potential Therapeutic Target to Control the Development and Progression of Amyotrophic Lateral Sclerosis Impaired antioxidant KEAP1-NRF2 system in
Description
When the course is completed, this event will be automatically marked as "Complete"
Table 2 lists the involvement of different GST isoforms in drug-resistant chemotherapies and related antineoplastic drugs
doi: 10.3892/ijmm.2022.5171 317
injections of 200 nmol kg 1 MK-801 (n = 8 mice and n = 4 cages), 600 nmol kg 1 MK-801 (n = 7 mice and n = 4 cages) or vehicle (isotonic saline, n = 7 mice and n = 4 cages) for 7 days
Inject slowly and steadily to minimize leakage and support accurate delivery
Sivakumar, T., Mechanic, O., Fehmie, D
